Literature DB >> 23001814

Proteomic analysis of the mice hippocampus after preconditioning induced by N-methyl-D-aspartate (NMDA).

Gabrielle do Amaral e Silva Müller1, Samuel Vandresen-Filho, Carolina Pereira Tavares, Angela C O Menegatti, Hernán Terenzi, Carla Inês Tasca, Patricia Cardoso Severino.   

Abstract

Preconditioning induced by N-methyl-D-aspartate (NMDA) has been used as a therapeutic tool against later neuronal insults. NMDA preconditioning affords neuroprotection against convulsions and cellular damage induced by the NMDA receptor agonist, quinolinic acid (QA) with time-window dependence. This study aimed to evaluate the molecular alterations promoted by NMDA and to compare these alterations in different periods of time that are related to the presence or lack of neuroprotection. Putative mechanisms related to NMDA preconditioning were evaluated via a proteomic analysis by using a time-window study. After a subconvulsant and protective dose of NMDA administration mice, hippocampi were removed (1, 24 or 72 h) and total protein analyzed by 2DE gels and identified by MALDI-TOF. Differential protein expression among the time induction of NMDA preconditioning was observed. In the hippocampus of protected mice (24 h), four proteins: HSP70(B), aspartyl-tRNA synthetase, phosphatidylethanolamine binding protein and creatine kinase were found to be up-regulated. Two other proteins, HSP70(A) and V-type proton ATPase were found down-regulated. Proteomic analysis showed that the neuroprotection induced by NMDA preconditioning altered signaling pathways, cell energy maintenance and protein synthesis and processing. These events may occur in a sense to attenuate the excitotoxicity process during the activation of neuroprotection promoted by NMDA preconditioning.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001814     DOI: 10.1007/s12031-012-9888-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  NMDA preconditioning protects against quinolinic acid-induced seizures via PKA, PI3K and MAPK/ERK signaling pathways.

Authors:  Bruno de Araújo Herculano; Samuel Vandresen-Filho; Wagner Carbolin Martins; Carina Rodrigues Boeck; Carla Inês Tasca
Journal:  Behav Brain Res       Date:  2010-12-24       Impact factor: 3.332

Review 2.  HUPO Brain Proteome Project: aims and needs in proteomics.

Authors:  Michael Hamacher; Helmut E Meyer
Journal:  Expert Rev Proteomics       Date:  2005-01       Impact factor: 3.940

3.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Neurotoxic and neurotrophic effects of chronic N-methyl-D-aspartate exposure upon mesencephalic dopaminergic neurons in organotypic culture.

Authors:  B G Dickie; C Holmes; S A Greenfield
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

5.  Neuroprotective effects of preconditioning ischemia on ischemic brain injury through down-regulating activation of JNK1/2 via N-methyl-D-aspartate receptor-mediated Akt1 activation.

Authors:  Bei Miao; Xiao-Hui Yin; Dong-Sheng Pei; Quan-Guang Zhang; Guang-Yi Zhang
Journal:  J Biol Chem       Date:  2005-03-29       Impact factor: 5.157

6.  Targeted disruption of the mouse gene encoding the V-ATPase accessory subunit Ac45.

Authors:  Vincent Th G Schoonderwoert; Gerard J M Martens
Journal:  Mol Membr Biol       Date:  2002 Jan-Mar       Impact factor: 2.857

Review 7.  Cell signaling in NMDA preconditioning and neuroprotection in convulsions induced by quinolinic acid.

Authors:  Patricia Cardoso Severino; Gabriele do Amaral Silva Muller; Samuel Vandresen-Filho; Carla Inês Tasca
Journal:  Life Sci       Date:  2011-06-13       Impact factor: 5.037

Review 8.  Neurotransmitter release: the dark side of the vacuolar-H+ATPase.

Authors:  N Morel
Journal:  Biol Cell       Date:  2003-10       Impact factor: 4.458

9.  Increase in secretion of glial cell line-derived neurotrophic factor from glial cell lines by inhibitors of vacuolar ATPase.

Authors:  Mariko Nishiguchi; Kimiko Tokugawa; Kyoko Yamamoto; Tomoko Akama; Yuriko Nozawa; Shigeyuki Chaki; Tomokazu Ueki; Kazuya Kameo; Shigeru Okuyama
Journal:  Neurochem Int       Date:  2003-05       Impact factor: 3.921

10.  Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis.

Authors:  Vinay K Dhodda; Kurt A Sailor; Kellie K Bowen; Raghu Vemuganti
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

View more
  4 in total

Review 1.  The Role of NMDA Receptors in the Development of Brain Resistance through Pre- and Postconditioning.

Authors:  Leandra Celso Constantino; Carla Inês Tasca; Carina Rodrigues Boeck
Journal:  Aging Dis       Date:  2014-02-12       Impact factor: 6.745

2.  Neuroprotection induced by NMDA preconditioning as a strategy to understand brain tolerance mechanism.

Authors:  Leandra C Constantino; Samuel Vandresen-Filho; Carla I Tasca
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

3.  Determination of neuroinflammatory biomarkers in autistic and neurotypical Saudi children.

Authors:  Najat O Hamed; Mohamed A Osman; Abdalla O Elkhawad; Geir Bjørklund; Hanan Qasem; Naima Zayed; Afaf El-Ansary
Journal:  Metab Brain Dis       Date:  2019-05-30       Impact factor: 3.584

4.  Neuroproteome changes after ischemia/reperfusion injury and tissue plasminogen activator administration in rats: a quantitative iTRAQ proteomics study.

Authors:  Zamir Merali; Meah MingYang Gao; Tim Bowes; Jian Chen; Kenneth Evans; Andrea Kassner
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.